Vogt–Koyanagi–Harada-like uveitis with severe hyalitis during treatment by anti-programmed death 1 antibody for lung cancer: a case report

Key Points

• Evaluate the occurrence of Vogt-Koyanagi-Harada-like uveitis linked to anti-PD-1 therapy in lung cancer treatments.
• Case report of a patient with lung cancer receiving anti-PD-1 antibody therapy.
• Observation of severe hyalitis and associated uveitis during treatment.
• Review of corticosteroid treatment effectiveness for managing uveitis.
• Patient developed severe hyalitis while on anti-PD-1 therapy.
• Corticosteroid treatment was found to be effective for managing the uveitis symptoms.
• Need for clearer guidelines on the optimal dosage and mode of corticosteroid therapy.